Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Clinical trial NCT03905642 · COMPLETED

Trial details

NCT number: NCT03905642
Sponsor: Insmed Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2009-01-08
Primary completion: 2010-11-02
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.